markerpen

markerpen identifies cell-type-specific marker genes from bulk transcriptome data by analyzing gene co-expression patterns to refine candidate marker lists for downstream analyses such as deconvolution.


Key Features:

  • Identification from Bulk Data: Leverages the correlation structure in bulk transcriptome data, exploiting that marker genes for a given cell type show high correlation across tissue samples because their measured expression is driven by cell-type proportion.
  • Semi-Supervised Algorithm: Integrates published information about potential marker genes with bulk transcriptome data using a semi-supervised approach to evaluate candidate markers.
  • Refinement Process: Refines candidate marker lists by adding or removing genes based on their correlation patterns in the analyzed bulk samples to improve marker accuracy and reliability.
  • Implementation: Provided as an R package for computational analysis of marker gene identification from bulk data.

Scientific Applications:

  • Deconvolution Studies: Enables estimation of cell-type composition in mixed tissue samples by providing refined cell-type-specific marker genes.
  • Gene Expression Analysis: Supports improved interpretation of tissue- and condition-specific expression patterns by identifying reliable marker genes from bulk data.

Methodology:

Analyzes the correlation structure of bulk transcriptome data and applies a semi-supervised algorithm that integrates published candidate marker lists with bulk data to refine markers by adding or removing genes based on correlation patterns.

Topics

Details

License:
GPL-2.0
Tool Type:
library
Programming Languages:
R
Added:
10/9/2021
Last Updated:
11/24/2024

Operations

Data Inputs & Outputs

Deisotoping

Inputs

Publications

Qiu Y, Wang J, Lei J, Roeder K. Identification of cell-type-specific marker genes from co-expression patterns in tissue samples. Bioinformatics. 2021;37(19):3228-3234. doi:10.1093/bioinformatics/btab257. PMID:33904573. PMCID:PMC8504631.

PMID: 33904573
PMCID: PMC8504631
Funding: - National Institutes of Health: AG02219, AG05138, HHSN271201300031C, MH06692, P50M096891, P50MH066392, P50MH080405, P50MH084053S1, R01MH085542, R01MH093725, R01MH097276, R01MH109677, R01MH109897, R01MH110921, R37MH057881, RO1-MH-075916, U01MH103392 - NIA: P30AG10161, R01AG15819, R01AG17917, R01AG30146, R01AG36042, R01AG36836, R01AG48015, RC2AG036547, RF1AG57473, U01AG32984, U01AG46152, U01AG46161, U01AG61356 - National Institute of Mental Health: R01MH123184, R37MH057881, UO1NH122681 - National Science Foundation: DMS-1553884, DMS-2015492

Documentation